CYCN insider trading
NasdaqCM HealthcareKorsana Biosciences, Inc.: insider trade history from SEC Form 4 filings.
About Korsana Biosciences, Inc.
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Company website: www.cyclerion.com
CYCN insider activity at a glance
FilingIQ tracks 68 insider transactions for CYCN in filings since Apr 2, 2019. The most recent transaction is dated Aug 14, 2026.
Across the full history, 14 open-market purchases
and 10 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest CYCN Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CYCN?
- FilingIQ tracks 68 Form 4 insider transactions for CYCN (Korsana Biosciences, Inc.), covering filings from Apr 2, 2019 onwards. 3 of those are dated within the last 90 days.
- Are CYCN insiders net buyers or net sellers?
- Across the full Form 4 history for CYCN, 14 transactions (21%) were open-market purchases and 10 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CYCN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is CYCN in?
- Korsana Biosciences, Inc. (CYCN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.73M.
Methodology & sources
Every CYCN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.